These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26023803)

  • 21. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.
    Agostini M; Janssen KP; Kim IJ; D'Angelo E; Pizzini S; Zangrando A; Zanon C; Pastrello C; Maretto I; Digito M; Bedin C; Jurisica I; Rizzolio F; Giordano A; Bortoluzzi S; Nitti D; Pucciarelli S
    Oncotarget; 2015 Oct; 6(32):32561-74. PubMed ID: 26359356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Cancer Genomics Proteomics; 2011; 8(2):87-92. PubMed ID: 21471518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
    Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
    Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy.
    Huang MY; Huang JJ; Huang CM; Lin CH; Tsai HL; Huang CW; Chai CY; Lin CY; Wang JY
    World J Surg; 2017 Nov; 41(11):2884-2897. PubMed ID: 28608017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Caramés C; Cristóbal I; Moreno V; del Puerto L; Moreno I; Rodriguez M; Marín JP; Correa AV; Hernández R; Zenzola V; Hernández T; León A; Martín JI; Sánchez-Fayos P; García-Olmo D; Rojo F; Goel A; Fernandez-Aceñero MJ; García-Foncillas J
    Int J Colorectal Dis; 2015 Jul; 30(7):899-906. PubMed ID: 25953218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.
    Cho E; Park IJ; Yeom SS; Hong SM; Lee JB; Kim YW; Kim MJ; Lim HM; Lim SB; Yu CS; Kim JC
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):834-842. PubMed ID: 31419511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Luna-Pérez P; Segura J; Alvarado I; Labastida S; Santiago-Payán H; Quintero A
    Ann Surg Oncol; 2000 Dec; 7(10):727-31. PubMed ID: 11129419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer.
    Nakao T; Iwata T; Hotchi M; Yoshikawa K; Higashijima J; Nishi M; Takasu C; Eto S; Teraoku H; Shimada M
    Oncol Rep; 2015 Oct; 34(4):1961-7. PubMed ID: 26260776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer.
    Kim NK; Hur H
    Yonsei Med J; 2015 Nov; 56(6):1461-77. PubMed ID: 26446626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    Campayo M; Navarro A; Benítez JC; Santasusagna S; Ferrer C; Monzó M; Cirera L
    PLoS One; 2018; 13(11):e0206542. PubMed ID: 30388154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
    Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
    Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
    Palma P; Cuadros M; Conde-Muíño R; Olmedo C; Cano C; Segura-Jiménez I; Blanco A; Bueno P; Ferrón JA; Medina P
    PLoS One; 2013; 8(9):e74034. PubMed ID: 24040155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
    Alderdice M; Dunne PD; Cole AJ; O'Reilly PG; McArt DG; Bingham V; Fuchs MA; McQuaid S; Loughrey MB; Murray GI; Samuel LM; Lawler M; Wilson RH; Salto-Tellez M; Coyle VM
    Mod Pathol; 2017 Sep; 30(9):1287-1298. PubMed ID: 28621318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.
    Casado E; Garcia VM; Sánchez JJ; Gómez Del Pulgar MT; Feliu J; Maurel J; Castelo B; Moreno Rubio J; López RA; García-Cabezas MÁ; Burgos E; de Castro J; Belda-Iniesta C; López-Gómez M; Gómez-Raposo C; Zambrana F; Sereno M; Fernández-Martos C; Vázquez P; Lacal JC; González-Barón M; Cejas P
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1151-8. PubMed ID: 22516806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
    Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
    Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
    Hur H; Tulina I; Cho MS; Min BS; Koom WS; Lim JS; Ahn JB; Kim NK
    Dis Colon Rectum; 2016 Dec; 59(12):1174-1182. PubMed ID: 27824703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-519b-3p promotes responsiveness to preoperative chemoradiotherapy in rectal cancer patients by targeting ARID4B.
    Luo J; Liu L; Zhou N; Shen J; Sun Q; Zhu Y; Chen M
    Gene; 2018 May; 655():84-90. PubMed ID: 29477868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.